Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Discovery Explains Why Influenza B Virus Exclusively Infects Humans

Opens Door for Drugs to Fight Seasonal Epidemics Caused by Virus

Rutgers, University of Texas at Austin researchers determine three-dimensional structure of site on influenza B virus protein that suppresses human defenses to infection

Researchers at Rutgers University and the University of Texas at Austin have reported a discovery that could help scientists develop drugs to fight seasonal influenza epidemics caused by the common influenza B strain.

Their discovery also helps explain how influenza B is limited to humans, and why it cannot be as virulent as A strains that incorporate new genes from influenza viruses that infect other species. The devastating flu pandemic of 1918, the pandemics of 1968 and 1977, and the avian influenza that emerged in the middle of the last decade were caused by influenza A viruses. Understanding features of influenza B virus that limit it to humans will help scientists better understand how influenza A strains are able to cross species.

The researchers have determined the three-dimensional structure of a complex between an influenza B virus protein and one of its human protein targets, resulting in suppression of the cell’s natural defenses to the infection and paving the way for the virus to replicate efficiently.

Their findings are detailed in a paper published in the most recent issue of PNAS (Proceedings of the US National Academy of Sciences).

“Our study shows the basis by which non-structural protein 1 of influenza B, or NS1B, binds to a human host protein, immobilizing it to prevent it from fighting the virus,” said Gaetano Montelione, a lead author and professor of biochemistry and molecular biology, School of Arts and Sciences, at Rutgers. That human protein, known as interferon-stimulated gene 15 protein or ISG15, is an essential part of the defense mechanism that human cells use to protect themselves from viral infections. Chemicals that block the binding of NS1B to ISG15 may have antiviral potential against influenza B virus.

The study, led by professors Montelione and Robert Krug at the University of Texas at Austin, also reveals why NS1B cannot bind ISG15 molecules in other species, such as dogs or mice. Only human and non-human primate ISG15 proteins have a unique molecular sequence in a small part of the protein that makes it possible to bind to the NS1B protein. So far, influenza B virus has been found only in humans.

“The three-dimensional structure of the NS1B-ISG15 complex, which we determined using X-ray crystallography, has given us a clear understanding of the molecular basis for this species specificity,” said Krug, professor and chair of molecular genetics and microbiology.

“Flu infections continue to be a major health problem, with more effective drugs critically needed to treat infected individuals and control potential pandemics,” said Aaron Shatkin, director of the Center for Advanced Biotechnology and Medicine (CABM) at Rutgers and an eminent virologist. “This discovery opens new possibilities for achieving these very important goals.”

Participating in the study from Rutgers were Rongjin Guan, Li-Ching Ma and Brendan Amer, who along with Montelione are members of CABM and the Northeast Structural Genomics Consortium. They were joined by Paul Leonard of the Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, who is also a member of CABM and the Howard Hughes Medical Institute. Participating from the University of Texas at Austin were Haripriya Sridharan and Chen Zhao, who along with Krug are also members of the university’s Institute for Cellular and Molecular Biology.

Montelione is the Jerome and Lorraine Aresty Chair in Cancer Research at Rutgers, an endowed chair established to support Montelione’s research efforts in the general area of cancer biology research. Significantly, some of the human proteins that are targets of the influenza virus’s defense mechanisms, like ISG15, are also important in cancer biology. Krug is a Fellow of the Mr. And Mrs. Corbin J. Robertson, Sr. Regents Chair in Molecular Biology at the University of Texas at Austin.

The work was supported by grants from the Protein Structure Initiative (PSI-Biology) Program of the National Institutes of Health and its National Institute of General Medical Sciences, the National Institute of Allergy and Infectious Disease, and the Howard Hughes Medical Institute.

Media Contact: Carl Blesch
732-932-7084, ext. 616
Contact: Lee Clippard

Carl Blesch | EurekAlert!
Further information:

More articles from Life Sciences:

nachricht Molecular doorstop could be key to new tuberculosis drugs
20.03.2018 | Rockefeller University

nachricht Modified biomaterials self-assemble on temperature cues
20.03.2018 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Physicists made crystal lattice from polaritons

20.03.2018 | Physics and Astronomy

Mars' oceans formed early, possibly aided by massive volcanic eruptions

20.03.2018 | Physics and Astronomy

Thawing permafrost produces more methane than expected

20.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>